Nurix Therapeutics NRIX
$12.85 −$0.75 (-5.51%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.85 0.00%
Open$13.40
Prev close$13.60
Day range$12.83 – $13.67
Volume2.43M
Market cap$1.40B
P/E (TTM)5.3
Dividend yield–
NRIX Stock News
Headlines matching Nurix Therapeutics or the NRIX ticker, most recent first.
- Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
- RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36 Positive
- Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $45
- Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $38 Positive
- Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $38
- UBS Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $31 Positive
- Wells Fargo Maintains Nurix Therapeutics(NRIX.US) With Hold Rating, Maintains Target Price $25
- Mizuho Securities Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $34 Positive
- A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40
- BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
- Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Nurix Therapeutics (NRIX) and Immunic (IMUX)
- A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $45
- Oppenheimer Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $28
- Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
- J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy Rating
No comments yet — be the first to weigh in on NRIX.
Sign in to join the discussion.